Jefferies Starts ProNAi Therapeutics (DNAI) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Jefferies Starts ProNAi Therapeutics (DNAI) at Buy

Wedbush Starts ProNAi Therapeutics (DNAI) at Outperform

August 10, 2015 7:34 AM EDT

Wedbush initiates coverage on ProNAi Therapeutics (NASDAQ: DNAI) with a Outperform rating and a price target of $36.00.

Analyst David Nierengarten commented, "DNAI is a clinical-stage biotech company developing a novel therapeutic platform based on DNA interference (DNAi). ProNAi's lead candidate, PNT2258, is a... More

BofA/Merrill Lynch Starts ProNAi Therapeutics (DNAI) at Buy

August 10, 2015 7:26 AM EDT

BofA/Merrill Lynch initiated coverage on ProNAi Therapeutics (NASDAQ: DNAI) with a Buy rating and a price target of $35.00.

For an analyst ratings summary and ratings history on ProNAi Therapeutics click here. For more ratings news on ProNAi Therapeutics click here.

Shares of ProNAi Therapeutics closed at $28.56 yesterday.

... More